CSIR Central

Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines

IR@CDRI: CSIR-Central Drug Research Institute, Lucknow

View Archive Info
 
 
Field Value
 
Creator Sunduru, Naresh
Nishi
Palne, Shraddha
Chauhan, P M S
Gupta, Suman
 
Date 2010-08-27T05:46:09Z
2010-08-27T05:46:09Z
2009
 
Identifier European Journal of Medicinal Chemistry, 44, I6, 2009, 2473-2481
http://hdl.handle.net/123456789/573
 
Description A series of 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines have been synthesized and screened for their in vitro and in vivo antileishmanial activity against L. donovani. Among all, 14 compounds have shown promising inhibition of 80-100% at 10 µg/ml against promastigotes and IC50 in the range of 0.89-9.68 µg/ml against amastigotes. Three compounds 13, 32 and 33 with good selectivity index (S.I) were screened for their in vivo activity in golden hamsters (Mesocricetus auretus) infected with MHOM/IN/80/Dd8 strain of L. donovani and have shown moderate in vivo inhibition of 48-56 % at a dose of 50 mg/Kgx5, I.P route for 5 days.
 
Format 185610 bytes
application/pdf
 
Language en
 
Subject Leishmaniasis
pyrimidine
1,3,5-triazine
 
Title Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines
 
Type Article